Patent · US Active

Facultatively attenuated bacterial species and methods of preparation and use thereof

US9511129B2 · kind B2 · utility

8Cited by
9References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2013
Grant dateDec 6, 2016
Priority date
Expiry dateNov 6, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides facultatively attenuated bacterial species and methods of preparation and use thereof. The term “facultatively attenuated” as used herein refers to a bacterium which comprises a set of defined recombinant modifications which have substantially no effect on the ability of the bacterium to grow by multiplication when the bacterium is outside of its host organism, but which result in deletion of one or more genes essential for multiplication of the bacterium when the bacterium is introduced into its host organism, for example within host cells of a vaccinate recipient. These recombinant modifications take advantage of regulatory sequences which preferentially induce expression of genes within the mammalian host.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.